| DNA replication |
2.05 |
0.00e+0 |
34/36 (94.44%) |
PCNA;POLE3;FEN1;...
|
| Epstein-Barr virus infection |
2.01 |
6.26e-3 |
189/202 (93.56%) |
MYC;HLA-B;HLA-F;...
|
| Hematopoietic cell lineage |
2.00 |
4.17e-3 |
90/99 (90.91%) |
CD59;CD36;ITGA6;...
|
| Allograft rejection |
1.92 |
1.25e-2 |
32/38 (84.21%) |
HLA-B;HLA-F;HLA-DRB1;...
|
| Th1 and Th2 cell differentiation |
1.90 |
1.50e-2 |
80/92 (86.96%) |
JAG1;MAF;HLA-DRB1;...
|
| Type I diabetes mellitus |
1.89 |
1.88e-2 |
38/43 (88.37%) |
HLA-B;HLA-F;HLA-DRB1;...
|
| TNF signaling pathway |
1.86 |
2.32e-2 |
103/112 (91.96%) |
JAG1;MMP9;CXCL1;...
|
| Cellular senescence |
1.85 |
2.19e-2 |
139/156 (89.1%) |
MYC;HLA-B;HLA-F;...
|
| Viral carcinogenesis |
1.84 |
2.22e-2 |
149/203 (73.4%) |
ACTN1;HDAC9;GSN;...
|
| MicroRNAs in cancer |
1.84 |
2.00e-2 |
146/310 (47.1%) |
MMP9;TNC;PRKCB;...
|
| Th17 cell differentiation |
1.80 |
2.50e-2 |
95/107 (88.79%) |
HLA-DRB1;IL1RAP;TGFBR2;...
|
| Graft-versus-host disease |
1.80 |
2.29e-2 |
32/42 (76.19%) |
HLA-B;HLA-F;HLA-DRB1;...
|
| Rheumatoid arthritis |
1.79 |
2.21e-2 |
78/93 (83.87%) |
ATP6V1D;CXCL1;HLA-DRB1;...
|
| Human T-cell leukemia virus 1 infection |
1.76 |
2.32e-2 |
197/219 (89.95%) |
MMP7;CDC20;MYC;...
|
| Regulation of lipolysis in adipocytes |
1.75 |
2.17e-2 |
52/55 (94.55%) |
PLAAT3;PTGER3;FABP4;...
|
| Ribosome biogenesis in eukaryotes |
1.75 |
2.11e-2 |
52/108 (48.15%) |
NOP56;NXT1;GTPBP4;...
|
| Hepatitis B |
1.74 |
2.21e-2 |
151/162 (93.21%) |
MMP9;PCNA;PRKCB;...
|
| Human cytomegalovirus infection |
1.73 |
2.43e-2 |
201/225 (89.33%) |
PRKCB;MYC;HLA-B;...
|
| NOD-like receptor signaling pathway |
1.72 |
2.37e-2 |
145/181 (80.11%) |
CXCL1;GBP1;OAS2;...
|
| Antigen processing and presentation |
1.72 |
2.25e-2 |
60/78 (76.92%) |
HLA-B;HLA-F;HLA-DRB1;...
|
| Notch signaling pathway |
1.71 |
2.50e-2 |
49/59 (83.05%) |
JAG1;MFNG;HEY2;...
|
| Kaposi sarcoma-associated herpesvirus infection |
1.71 |
2.50e-2 |
172/193 (89.12%) |
RCAN1;MYC;HLA-B;...
|
| Non-homologous end-joining |
1.71 |
2.39e-2 |
11/13 (84.62%) |
PRKDC;FEN1;DNTT;...
|
| Autoimmune thyroid disease |
1.70 |
2.55e-2 |
46/53 (86.79%) |
HLA-B;HLA-F;HLA-DRB1;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.69 |
2.75e-2 |
97/100 (97%) |
PRKCB;TGFBR2;PLCB1;...
|
| Mismatch repair |
1.68 |
2.84e-2 |
22/23 (95.65%) |
PCNA;RPA1;RFC3;...
|
| Chemokine signaling pathway |
1.67 |
3.20e-2 |
163/192 (84.9%) |
CXCL14;PRKCB;CXCL1;...
|
| Human immunodeficiency virus 1 infection |
1.65 |
3.35e-2 |
189/212 (89.15%) |
PRKCB;HLA-B;HLA-F;...
|
| C-type lectin receptor signaling pathway |
1.65 |
3.28e-2 |
93/104 (89.42%) |
PTGS2;AKT3;NRAS;...
|
| IL-17 signaling pathway |
1.63 |
3.42e-2 |
84/94 (89.36%) |
MMP9;IL17RB;CXCL1;...
|
| Pyruvate metabolism |
-1.60 |
4.76e-2 |
41/47 (87.23%) |
ALDH7A1;GRHPR;ALDH3A2;...
|
| Alanine, aspartate and glutamate metabolism |
-1.61 |
4.71e-2 |
27/37 (72.97%) |
GLUD1;CPS1;AGXT;...
|
| beta-Alanine metabolism |
-1.61 |
4.95e-2 |
25/30 (83.33%) |
HADHA;CNDP2;MLYCD;...
|
| Caffeine metabolism |
-1.62 |
4.74e-2 |
5/6 (83.33%) |
NAT2;NAT1
|
| Glycine, serine and threonine metabolism |
-1.66 |
3.90e-2 |
31/40 (77.5%) |
AGXT;SRR;ALDH7A1;...
|
| Ribosome |
-1.68 |
3.67e-2 |
113/158 (71.52%) |
RPS16;MRPS11;RPL27A;...
|
| Synthesis and degradation of ketone bodies |
-1.68 |
4.08e-2 |
9/10 (90%) |
ACAT1;HMGCL;HMGCS1;...
|
| Histidine metabolism |
-1.70 |
3.20e-2 |
16/22 (72.73%) |
ALDH7A1;ALDH3A2;ALDH3B1;...
|
| Metabolism of xenobiotics by cytochrome P450 |
-1.72 |
2.97e-2 |
49/77 (63.64%) |
MGST2;GSTM3;CYP2D6;...
|
| Primary bile acid biosynthesis |
-1.73 |
3.23e-2 |
15/17 (88.24%) |
CYP39A1;AKR1C4;ACOT8;...
|
| Steroid biosynthesis |
-1.82 |
1.66e-2 |
19/20 (95%) |
MSMO1;HSD17B7;CYP51A1;...
|
| Fatty acid degradation |
-1.84 |
6.93e-3 |
40/43 (93.02%) |
ACOX3;ALDH7A1;ALDH3A2;...
|
| Valine, leucine and isoleucine degradation |
-1.91 |
2.31e-3 |
42/48 (87.5%) |
ACAD8;AUH;MCCC1;...
|
| Butanoate metabolism |
-1.98 |
0.00e+0 |
23/28 (82.14%) |
ACAT1;AACS;EHHADH;...
|
| Complement and coagulation cascades |
-2.19 |
0.00e+0 |
76/85 (89.41%) |
BDKRB1;F10;C8G;...
|
